Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Roche Basel Switzerland

Roche sets disruptive price for new MS drug Ocrevus in US

Firm will significantly under cut rivals like Merck's Rebif

- PMLiVE

UK pharma strikes optimistic note as Brexit process begins

Says life science industry is accustomed to ‘uncertainty’ and can thrive in a post-EU Britain

- PMLiVE

90TEN appoints new associate director

Stephanie O’Hagan joins the firm from Ketchum

- PMLiVE

Brexit begins as UK PM signs letter triggering Article 50

Theresa May sets wheels in motion as Britain awaits EU response

LEO Innovation Lab picks next health tech startups to support

Dermatology and mental health firms to receive funds

- PMLiVE

Hayward Medical Communications adds to its team

Paul Thomas and Alice Pinion among the UK agency's new recruits

- PMLiVE

Regeneron bags US approval for eczema drug Dupixent

Aims to balance affordability and rewarding innovation with the treatment's pricing

- PMLiVE

Channel strategy and channeling your inner disrupter

Is this the answer to many of today's marketing challenges?

- PMLiVE

MMRI strengthens leadership team with new commercial director

Colin Williams joins the firm from PharmiWeb Solutions

- PMLiVE

Pfizer resurrects its OTC bid for Viagra in the UK

Confirms MHRA review of new pharmacist-supplied status has begun

ABPI London offices

Nearly half of HCPs refuse to disclose pharma payments

Industry data shows firms spent £363m on working with healthcare professionals

National Institute for Health and Care Excellence NICE logo

NICE knocks-back Shire’s pancreatic cancer drug Onivyde

Final guidance rules it's not a cost-effective use of NHS resources

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links